Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glibenclamide in edema after intracerebral hemorrhage
NCT03741530Completed
- Sponsor
- Xijing Hospital
- Start
- Dec 2018
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of glibenclamide in intracerebral hemorrhage (ICH), sponsored by Xijing Hospital. Started Dec 2018; status: completed.
02
Drugs
glibenclamide
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT03741530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03741530.